Manufacturing challenges surround the use of IgM monoclonal antibodies, but these can be overcome with current technology.
Richard Richieri
Advertisement
Vice President of Manufacturing and Research and Development at Avid Biosciences, Inc.
Articles by Richard Richieri
Advertisement
Latest Updated Articles
Purification of IgM Monoclonal AntibodiesMarch 2nd 2008
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
3
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
4
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
5